12/20/2023 0 Comments Illstarred gets cautious thumbsupThen he proceeded to lay out the details of an ambitious clinical trial. "We know the FDA is concerned about this," he conceded, and deleted the offensive phrase. "They're products."īarzilai, a 59-year-old with a boyish mop of gray hair, wore a contrite grin. "I wouldn't dignify them by calling them 'treatments,'" added Michael Pollak, director of cancer prevention at McGill University in Montreal, Canada. The phrase "anti-aging … has an association that is negative." Jay Olshansky, a biodemographer of aging from the University of Illinois, Chicago. He had barely begun to explain the rationale for the trial when he mentioned, in passing, "lots of unproven, untested treatments under the category of anti-aging." His colleagues pounced. But his practice run kept hitting a historical speed bump. To anyone who has seen the ebullient scientist in his natural laboratory habitat, often in a short-sleeved shirt and always cracking jokes, he looked uncharacteristically kempt in a blue blazer and dress khakis. After Austad's brief introductory remarks, a scientist named Nir Barzilai tuned up his PowerPoint and launched into a practice run of the main presentation.īarzilai is a former Israeli army medical officer and head of a well-known study of centenarians based at the Albert Einstein College of Medicine in the Bronx, New York. ![]() "We think this is a groundbreaking, perhaps paradigm-shifting trial," said Steven Austad, chairman of biology at the University of Alabama, Birmingham, and scientific director of the American Federation for Aging Research (AFAR). Food and Drug Administration (FDA), a few kilometers away, to pitch an unprecedented clinical trial-nothing less than the first test of a drug to specifically target the process of human aging. In a few hours, the group would meet with officials at the U.S. On a blazingly hot morning this past June, a half-dozen scientists convened in a hotel conference room in suburban Maryland for the dress rehearsal of what they saw as a landmark event in the history of aging research.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |